D-1672-2012 Class II Terminated
FDA drug recall D-1672-2012 was initiated by Hospira Inc. on Aug 3, 2012 and is designated Class II. Reason for recall: Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection. The recall status is terminated (terminated May 6, 2014). Affected quantity: 56,420 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Sep 5, 2012
- Initiation Date
- Aug 3, 2012
- Termination Date
- May 6, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 56,420 vials
Product Description
Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 ml Single patient infusion vial, Rx only, Hospira, Inc. Lake Forest, IL 60045 USA, NDC 0409-4699-24
Reason for Recall
Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection.
Distribution Pattern
Nationwide
Code Information
07-893-DJ, exp. 7/2013, 10-123-DJ, 10-125-DJ, exp. 10/2013
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1672-2012
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026